Published in Cardiovascular Business Week, October 11th, 2005
Revenue for fiscal 2005 totaled $1,182,005 compared to $1,074,515 in the prior year ended June 30, 2004, which represents a 10% increase from the prior year. The company incurred a net loss of $1,455,228 for fiscal 2005 or $0.05 per share compared with a net loss of $1,839,949 for fiscal 2004 or $0.08 per share.
Included in the net loss of $1,455,228 for fiscal 2005 are total non-cash charges expenses associated with stock compensation, depreciation, stock options of $337,976. Included in the net loss of $1,839,949 for fiscal 2004 are total...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.